IDO1 and neoplasm: Evidence that tumours co-opt a similar mechanism to suppress the endogenous immunity of the host, followed from demonstrations that the enzyme is expressed by a broad range of clinical tumours and that IDO1 expression by experimental murine tumours prevented their rejection in pre-immunized mice [2].